{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:30:42Z","timestamp":1788474642272,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bbr.2021.113159","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T02:12:46Z","timestamp":1612836766000},"page":"113159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats"],"prefix":"10.1016","volume":"404","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-8522","authenticated-orcid":false,"given":"Heloisa H.","family":"Vilela-Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhonatan Christian","family":"Maraschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio C.","family":"Casarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz","family":"Sant\u2019Ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valquiria C.","family":"de Bortoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adrielle","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alline Cristina","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1200-0924","authenticated-orcid":false,"suffix":"Jr","given":"Helio","family":"Zangrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbr.2021.113159_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.bbr.2021.113159_bib0010","first-page":"CD004185","article-title":"Fluoxetine versus other types of pharmacotherapy for depression","author":"Magni","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2021.113159_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.9758\/cpn.2019.17.2.145","article-title":"Pharmacological therapy in panic disorder: current guidelines and novel drugs discovery for treatment-resistant patient","volume":"17","author":"Zulfarina","year":"2019","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.bbr.2021.113159_bib0020","doi-asserted-by":"crossref","first-page":"7e31","DOI":"10.1016\/0022-3956(88)90067-2","article-title":"Tricyclic therapy on the DSM-III anxiety disorders: a review with implications for further research","volume":"22","author":"Liebowitz","year":"1988","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2021.113159_bib0025","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1176\/appi.ajp.157.9.1423","article-title":"Timing of onset of antidepressant response with fluoxetine treatment","volume":"157","author":"Nierenberg","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2021.113159_bib0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"issue":"1615","key":"10.1016\/j.bbr.2021.113159_bib0035","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0536","article-title":"Serotonin and beyond: therapeutics for major depression","volume":"368","author":"Blier","year":"2013","journal-title":"Phil Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2021.113159_bib0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1871524911006030207","article-title":"The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders","volume":"10","author":"Graeff","year":"2010","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.bbr.2021.113159_bib0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neubiorev.2014.03.007","article-title":"Serotonin in anxiety and panic: contributions of the elevated T-maze","volume":"46","author":"Zangrossi","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2021.113159_bib0050","series-title":"Handbook of the Behavioral Neurobiology of Serotonin","first-page":"611","article-title":"Serotonin in panic and anxiety disorders","author":"Zangrossi","year":"2020"},{"key":"10.1016\/j.bbr.2021.113159_bib0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02245294","article-title":"Attenuation of chemically induced defense response by 5-HT1 receptor agonists administered into the periaqueductal gray","volume":"108","author":"Beckett","year":"1992","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2021.113159_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brainresbull.2004.06.007","article-title":"Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze","volume":"64","author":"De Paula Soares","year":"2004","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.bbr.2021.113159_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(94)00402-5","article-title":"Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion","volume":"52","author":"Nogueira","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bbr.2021.113159_bib0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF00428199","article-title":"Anti-aversive role of serotonin in the dorsal periaqueductal grey matter","volume":"85","author":"Sch\u00fctz","year":"1985","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2021.113159_bib0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(03)01970-8","article-title":"Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze","volume":"473","author":"Zanoveli","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113159_bib0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00213-005-0189-y","article-title":"Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray","volume":"183","author":"Bortoli","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2021.113159_bib0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002130050299","article-title":"Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats","volume":"131","author":"Mongeau","year":"1997","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.bbr.2021.113159_bib0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.fbp.0000179280.05654.5a","article-title":"Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety","volume":"16","author":"Zanoveli","year":"2005","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2021.113159_bib0095","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.neuropharm.2007.01.001","article-title":"Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze","volume":"52","author":"Zanoveli","year":"2007","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.bbr.2021.113159_bib0100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S146114570999099X","article-title":"Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine","volume":"13","author":"Zanoveli","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1-2","key":"10.1016\/j.bbr.2021.113159_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(03)03384-5","article-title":"Serotonin receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment","volume":"993","author":"Campbell","year":"2003","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2021.113159_bib0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-005-0108-2","article-title":") Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze","volume":"182","author":"De Mello Cruz","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.bbr.2021.113159_bib0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S1461145711000873","article-title":"Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration","volume":"15","author":"Vicente","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2021.113159_bib0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuropharm.2010.09.001","article-title":"5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray","volume":"60","author":"Yamashita","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113159_bib0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/FBP.0b013e32832c7098","article-title":"Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats","volume":"20","author":"Pelosi","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113159_bib0130","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.bbr.2021.113159_bib0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.bbr.2021.113159_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2021.113159_bib0145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fphar.2020.00260","article-title":"Chronic fluoxetine impairs the effects of 5-HT1A and 5-HT2C receptors activation in the PAG and amygdala on antinociception induced by aversive situation in mice","volume":"11","author":"Baptista-de-Souza","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113159_bib0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2014.08.001","article-title":"Disrupted MEK\/ERK signaling in the medial orbital cortex and dorsal endopiriform nuclei of the prefrontal cortex in a chronic restraint stress mouse model of depression","volume":"580","author":"Leem","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2021.113159_bib0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2008.05.003","article-title":"Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress","volume":"31","author":"Qi","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2021.113159_bib0160","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12035-016-0342-0","article-title":"Neuroprotective effects of antidepressants via upregulation of neurotrophic factors in the MPTP model of parkinson\u2019s disease","volume":"55","author":"Shadfar","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2021.113159_bib0165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1159\/000449165","article-title":"Chronic fluoxetine treatment upregulates the activity of the ERK1\/2-NF-\u03baB signaling pathway in the hippocampus and prefrontal cortex of rats exposed to forced-swimming stress","volume":"25","author":"Cui","year":"2016","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.bbr.2021.113159_bib0170","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.neuint.2011.10.007","article-title":"Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats","volume":"59","author":"Abelaira","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2021.113159_bib0175","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jpsychires.2012.04.016","article-title":"The administration of olanzapine and fluoxetine has synergistic effects on intracellular survival pathways in the rat brain","volume":"46","author":"R\u00e9us","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2021.113159_bib0180","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00213-018-5087-1","article-title":"Resveratrol exerts a protective effect in chronic unpredictable mild stress\u2013induced depressive-like behavior: involvement of the AKT\/GSK3\u03b2 signaling pathway in hippocampus","volume":"236","author":"Shen","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2021.113159_bib0185","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1007\/s12035-018-0919-x","article-title":"Fluoxetine Inhibits Natural Decay of Long-Term Memory via Akt\/GSK-3\u03b2 Signaling","volume":"55","author":"Yi","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2021.113159_bib0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.biopsych.2004.10.039","article-title":"Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine","volume":"57","author":"Roh","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113159_bib0195","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2021.113159_bib0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biochi.2018.10.015","article-title":"The 5-HT1A receptor: signaling to behavior","volume":"161","author":"Albert","year":"2019","journal-title":"Biochimie. Biochimie"},{"key":"10.1016\/j.bbr.2021.113159_bib0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuropharm.2013.11.007","article-title":"Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment","volume":"79","author":"Vicente","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113159_bib0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2013.03.005","article-title":"Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects","volume":"246","author":"Strauss","year":"2013","journal-title":"Behav. Brain Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:26:27Z","timestamp":1759065987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432821000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":42,"alternative-id":["S0166432821000462"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113159","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113159"}}